ING Groep NV Acquires 112,726 Shares of Ralliant Corporation $RAL

ING Groep NV increased its holdings in shares of Ralliant Corporation (NYSE:RAL) by 1,169.2% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 122,367 shares of the company’s stock after acquiring an additional 112,726 shares during the period. ING Groep NV owned about 0.11% of Ralliant worth $5,351,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in RAL. Manchester Capital Management LLC bought a new stake in shares of Ralliant in the 2nd quarter valued at approximately $29,000. Westfuller Advisors LLC bought a new position in shares of Ralliant during the 3rd quarter worth approximately $26,000. UMB Bank n.a. acquired a new stake in Ralliant in the 3rd quarter valued at $29,000. Evermay Wealth Management LLC acquired a new stake in Ralliant in the 2nd quarter valued at $32,000. Finally, Webster Bank N. A. bought a new stake in Ralliant in the third quarter valued at $31,000.

More Ralliant News

Here are the key news stories impacting Ralliant this week:

• Positive Sentiment: Company insiders have been buying shares, signaling management confidence — Director Kate Mitchell purchased 2,350 shares at ~$42.48 and Director Anelise Angelino Sacks bought 2,000 shares (disclosed in SEC filings). These purchases can support the stock and signal perceived undervaluation. Kate Mitchell SEC Filing Anelise Angelino Sacks SEC Filing
• Neutral Sentiment: Management will present at upcoming investor conferences (Citi and Barclays on Feb 17–18), offering a platform to clarify strategy and guidance — useful for investors seeking more detail but not an immediate catalyst. Conference Announcement
• Neutral Sentiment: Several sell‑side firms trimmed price targets (Barclays, Citigroup, Truist, Oppenheimer) — these lower targets reduce near‑term enthusiasm but many analysts retained positive ratings, leaving mixed guidance for investors. Barclays / Analyst Notes
• Negative Sentiment: Ralliant disclosed a roughly $1.4 billion non‑cash goodwill impairment in its Test & Measurement segment and reduced FY2026 guidance — a material accounting charge and weaker outlook that hit fundamentals and triggered large analyst re‑ratings. Impairment / Guidance Report
• Negative Sentiment: Multiple law firms (Levi & Korsinsky, Kessler Topaz, Block & Leviton, Kaplan Fox and others) have opened or publicized investigations into possible securities‑law violations related to the impairment timing/disclosure — raising litigation, regulatory and reputational risk. Kessler Topaz PR Block & Leviton Alert
• Negative Sentiment: Short interest rose sharply (~+58.7% in January to ~3.75M shares), amplifying downside pressure and intraday volatility as bearish positioning increases the risk of further selling on negative headlines.
• Negative Sentiment: Zacks downgraded Ralliant to a “strong sell,” adding to negative analyst momentum and likely contributing to selling pressure. Zacks Note

Insider Transactions at Ralliant

In other news, Director Kate Mitchell purchased 2,350 shares of the business’s stock in a transaction dated Tuesday, February 10th. The shares were acquired at an average price of $42.48 per share, with a total value of $99,828.00. Following the completion of the purchase, the director directly owned 8,411 shares of the company’s stock, valued at $357,299.28. The trade was a 38.77% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Anelise Angelino Sacks acquired 2,000 shares of the stock in a transaction that occurred on Monday, February 9th. The stock was purchased at an average price of $41.25 per share, with a total value of $82,500.00. Following the completion of the transaction, the director owned 5,403 shares of the company’s stock, valued at approximately $222,873.75. This trade represents a 58.77% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last ninety days, insiders have purchased 8,145 shares of company stock worth $332,233.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. Weiss Ratings downgraded shares of Ralliant from a “hold (c)” rating to a “sell (d)” rating in a research note on Thursday, February 5th. Citigroup reduced their price target on shares of Ralliant from $61.00 to $51.00 and set a “buy” rating on the stock in a research report on Friday, February 6th. Oppenheimer decreased their price objective on shares of Ralliant from $60.00 to $50.00 and set an “outperform” rating on the stock in a research note on Friday, February 6th. Vertical Research upgraded shares of Ralliant from a “hold” rating to a “buy” rating and set a $45.00 target price for the company in a research note on Friday, February 6th. Finally, Barclays decreased their price target on Ralliant from $60.00 to $52.00 and set an “overweight” rating on the stock in a research report on Monday. Seven investment analysts have rated the stock with a Buy rating, three have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, Ralliant has an average rating of “Hold” and an average target price of $50.50.

Ralliant Trading Down 0.1%

Shares of NYSE RAL opened at $42.68 on Friday. Ralliant Corporation has a 1-year low of $37.27 and a 1-year high of $57.02. The company has a 50-day moving average of $50.93 and a two-hundred day moving average of $46.59. The company has a market cap of $4.81 billion and a PE ratio of 21.78. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.38.

Ralliant (NYSE:RAL) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $0.69 earnings per share for the quarter, beating analysts’ consensus estimates of $0.67 by $0.02. The company had revenue of $554.60 million during the quarter, compared to analyst estimates of $543.04 million. Ralliant’s quarterly revenue was up 1.2% compared to the same quarter last year. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, March 23rd. Stockholders of record on Monday, March 9th will be paid a $0.05 dividend. This represents a $0.20 annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend is Monday, March 9th. Ralliant’s dividend payout ratio (DPR) is 10.20%.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.